Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
19-46
Author(s):
Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter
SUBJECT INDEX TO VOLUME 1
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
115-118
Author(s):
The Mouse In Cancer Research Past, Present, Future
Journal:
Current Genomics
Volume:
2
Page:
1-26
Author(s):
K. Hunter and D. Cozma
Bestatin as an Experimental Tool in Mammals
Journal:
Current Drug Metabolism
Volume:
2
Page:
67-85
Author(s):
O. A. Scornik and V. Botbol
Recent Advances in the Discovery of Protein Kinase C Modulators Based on the Structures of Natural Protein Kinase C Activators
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
191-202
Author(s):
Dawei Ma
Preclinical Evaluation of New Anthracyclines
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
9-13
Author(s):
G. Pratesi and S. V. Monestiroli
Role of Apoptosis and Apoptosis-Related Genes in Cellular Response and Antitumor Efficacy of Anthracyclines
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
31-37
Author(s):
Paola Perego, Elisabetta Corna, Michelandrea De Cesare, Laura Gatti, Donatella Polizzi, Graziella Pratesi, Rosanna Supino and Franco Zunino
Analysis of Drug Transport Kinetics in Multidrug-resistant Cells: Implications for Drug Action
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
51-64
Author(s):
Arlette Garnier-Suillerot, Carole Marbeuf-Gueye, Milena Salerno, Chatchanok Loetchutinat, Izabela Fokt, Marta Krawczyk, Teresa Kowalczyk and Waldemar Priebe
The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents
Journal:
Current Drug Targets
Volume:
1
Page:
327-364
Author(s):
M. Gardnerova, R. Blanque and C. R. Gardner
Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
303-312
Author(s):
Christine A. White, Judy R. Berlfein and Antonio J. Grillo-Lopez